Gastroenterologist Gianrico Farrugia, MD, has been named vice president and CEO of Mayo Clinic's Jacksonville, Fla., campus, according to an insurancenewsnet report.
GI & Endoscopy
A study recently published in the journal Gastroenterology, suggests that irinotecan-based therapy, when combined with standard chemotherapy treatment, may improve survival rates for a subset of patients with stage III colon cancer.
The market for colorectal cancer therapies will hold steady, valued at $7.7 billion by 2023, according to a Decision Resources Group news release.
Medigus, a medical device company focused on micro-cameras and endosurgical tools, has completed its private placement of $11.1 million, including shares and warrants.
The global endoscopy market is projected to reach $43 billion by 2019, according to a report from Research and Markets.
Advertisement
Colonoscopy has been the bread-and-butter procedure of the GI field for decades, but new technology continues to roll out. Ten GI physicians consider whether or not a new device will ever be able to replace this staple of the gastroenterology…
The American Society for Gastrointestinal Endoscopy, a National Colorectal Cancer Roundtable partner, has joined the new NCCRT initiative designed to improve colorectal cancer screening access and rates in community health centers.
Loveland (Colo.) Medical Enterprises has leased office space the Centers for Gastroenterology and Loveland (Colo.) Endoscopy Center, according to a Reporter-Herald report.
A recent study conducted in Norway has found that the removal of adenomatous polyps without a follow-up surveillance resulted in a colorectal cancer mortality rate comparable to that of the general population, according to a MedPage report.
A recent study published in The American Journal of Gastroenterology compared polyethylene glycol to Miralax and Gatorade as colonoscopy bowel preparation regimens. Here are four things to know about the study.